Tag: Johnson & Johnson

Novavax set for India launch with SII as mfg partner – ET HealthWorld

New Delhi: The uncertain path to authorisation in the US for Novavax despite passing the efficacy test with an impressive score of 90.4% might see India emerge as a major hub for the shots with the Serum Institute of India as manufacturing partner. The large Novavax trials conducted on 29,960 persons in the US and […]

Read More

Why big pharma had a responsibility to profit from the pandemic – ET HealthWorld

The pharmaceutical company Pfizer expects to earn up to US$26 billion (£18 billion) this year from the sale of its COVID-19 vaccine. Profits for the first quarter of 2021 are apparently 44% higher than they were a year ago. Similarly, Moderna expects to make US$18.4 billion (£13 billion), and record its first ever profit this […]

Read More

Thailand books 20 million doses of Pfizer-BioNTech Covid-19 vaccines – ET HealthWorld

Bangkok: Thailand has signed a purchase order for 20 million doses of the Covid-19 vaccine developed by Pfizer and BioNTech to be delivered before the end of this year, its health minister said. Details of the deal, delivery timeframe and the vaccine’s approval by the Food and Drug Administration would be worked out in about […]

Read More

Chile approves J&J’s Covid-19 vaccine for emergency use – ET HealthWorld

Chile‘s Institute of Public Health said on Thursday that it had approved the emergency use of Covid-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson. The single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization […]

Read More

EU foregoes 100 million J&J vaccines, considers donating other doses: sources – ET HealthWorld

(AP Photo/Mary Altaffer, File) By Francesco Guarascio and Elvira Pollina BRUSSELS – The European Union decided not to take up an option to buy 100 million doses of the Johnson & Johnson’s COVID-19 vaccine and is considering donating another 100 million optional shots, if ordered, European officials said. The discussions show a drop in confidence […]

Read More

J&J CEO says people will likely need Covid vaccine with annual flu shot for next several years as variants spread

Chairman and CEO of Johnson & Johnson Alex Gorsky speaks during an event at the South Court Auditorium of the Eisenhower Executive Office Building March 10, 2021 in Washington, DC. Alex Wong | Getty Images Johnson & Johnson CEO Alex Gorsky reiterated Wednesday that people will likely need to receive additional doses of the Covid-19 […]

Read More

Maldives gives emergency approval to Moderna, J&J vaccines – ET HealthWorld

The Maldives Food and Drug Administration (MFDA) has given emergency approval to the Covid-19 vaccines by Moderna and Johnson & Johnson as the island nation continues to battle the third wave of the pandemic. In a statement, the MFDA said that both vaccines could be used for individuals above the age of 18, reports Xinhua […]

Read More

EMA highlights guidance not to use heparin for Covid-19 vaccine-linked clots – ET HealthWorld

The European Medicines Agency (EMA) on Monday pushed guidance for doctors not to use the blood thinner heparin to treat rare blood clots and low blood platelets in people who got AstraZeneca‘s or Johnson & Johnson’s Covid-19 shots. Europe’s drugs regulator, seeking to ensure proper treatment, highlighted the International Society on Thrombosis and Haemostasis (ISTH) […]

Read More

India signs deal with domestic vaccine maker Biological-E for 300 million doses – ET HealthWorld

Bengaluru: India’s government said on Thursday it has inked a deal with domestic vaccine maker Biological-E for 300 million Covid-19 vaccine doses for 15 billion rupees ($205.62 million), the first such order for unapproved shots. The vaccine, which is currently undergoing phase-3 clinical trials, is likely to be available in the next few months, the […]

Read More

U.S. Supreme Court rebuffs J&J appeal over $2 billion baby powder judgement – ET HealthWorld

By Lawrence Hurley WASHINGTON – The U.S. Supreme Court on Tuesday declined to hear Johnson & Johnson’s bid to overturn a $2.12 billion damages award to women who blamed their ovarian cancer on asbestos in the company’s baby powder and other talc products. The justices turned away a J&J appeal and left in place a […]

Read More